PreveCeutical Medical (XCNQ:PREV) LT-Debt-to-Total-Asset : 0.00 (As of Sep. 2023)

View and export this data going back to 2016. Start your Free Trial

What is PreveCeutical Medical LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. PreveCeutical Medical's long-term debt to total assests ratio for the quarter that ended in Sep. 2023 was 0.00.

PreveCeutical Medical's long-term debt to total assets ratio declined from Mar. 2022 (11.21) to Sep. 2023 (0.00). It may suggest that PreveCeutical Medical is progressively becoming less dependent on debt to grow their business.

PreveCeutical Medical LT-Debt-to-Total-Asset Historical Data

The historical data trend for PreveCeutical Medical's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PreveCeutical Medical LT-Debt-to-Total-Asset Chart

PreveCeutical Medical Annual Data

Trend

Jul15

Jul16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

1.60

4.09

6.21

10.41

PreveCeutical Medical Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Sep23
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															11.21	12.71	0.39	-	-

PreveCeutical Medical LT-Debt-to-Total-Asset Calculation

PreveCeutical Medical's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2022 is calculated as

LT Debt to Total Assets (A: Dec. 2022 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2022 )	/	Total Assets (A: Dec. 2022 )
	=	0	/	0.189
	=

PreveCeutical Medical's Long-Term Debt to Total Asset Ratio for the quarter that ended in Sep. 2023 is calculated as

LT Debt to Total Assets (Q: Sep. 2023 )	=	Long-Term Debt & Capital Lease Obligation (Q: Sep. 2023 )	/	Total Assets (Q: Sep. 2023 )
	=	0	/	0.209
	=

PreveCeutical Medical (XCNQ:PREV) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

PreveCeutical Medical LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of PreveCeutical Medical's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

PreveCeutical Medical (XCNQ:PREV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PreveCeutical Medical Inc (XCNQ:PREV) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

PRVCF:USA 18H:Germany

Address

885 Cambie Street, Suite 2500, Vancouver, BC, CAN, V6B 0R6

Website

https://www.preveceutical.com

PreveCeutical Medical Inc is a health sciences company. Its principal business activity is the development of innovative options for preventive and curative therapies utilizing organic and nature-identical products. It is engaged in licensing, branding, and marketing nutraceutical and wellness products.

PreveCeutical Medical (XCNQ:PREV) Headlines

No Headlines